Strengthening Families & Communities LLC’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.9K Hold
506
0.02% 169
2026
Q1
$99.7K Sell
506
-3
-0.6% -$578 0.02% 171
2025
Q4
$93.6K Sell
509
-187
-27% -$32.8K 0.03% 113
2025
Q3
$107K Buy
+696
New +$105K 0.02% 205
2025
Q2
Sell
-120
Closed -$18.7K 409
2025
Q1
$18.7K Buy
+120
New +$17.4K 0.01% 205
2024
Q4
Sell
-448
Closed -$69.8K 348
2024
Q3
$69.8K Buy
448
+1
+0.2% +$161 0.02% 214
2024
Q2
$70K Hold
447
0.02% 224
2024
Q1
$60K Buy
447
+124
+38% +$16.4K 0.04% 100
2023
Q4
$43.4K Hold
323
0.03% 104
2023
Q3
$44K Sell
323
-304
-48% -$41.5K 0.02% 200
2023
Q2
$103K Buy
627
+106
+20% +$15.6K 0.04% 165
2023
Q1
$85 Buy
521
+145
+39% +$19.5K ﹤0.01% 153
2022
Q4
$63K Hold
376
0.04% 146
2022
Q3
$50K Buy
376
+66
+21% +$8.37K 0.03% 222
2022
Q2
$41K Hold
310
0.02% 157
2022
Q1
$41K Sell
310
-4
-1% -$480 0.03% 157
2021
Q4
$37 Buy
+314
New +$36.9K 0.01% 154

Other funds holding AZN

Strengthening Families & Communities LLC's AZN Position: Q2 2026 in Review

Strengthening Families & Communities LLC held its AstraZeneca (AZN) position steady in Q2 2026 at 506 shares worth $95.9K. The position accounts for 0.02% of the portfolio, ranked #169.

Strengthening Families & Communities LLC first reported a position in AZN in Q4 2021 and has held it in 17 quarters since. The position peaked at $107K in Q3 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Strengthening Families & Communities LLC held 506 shares of AstraZeneca worth $95.9K as of Q2 2026.
  • Strengthening Families & Communities LLC left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #169 holding.
  • Strengthening Families & Communities LLC first reported a position in AstraZeneca in Q4 2021 and has held it in 17 quarters since.
  • Strengthening Families & Communities LLC's AstraZeneca position peaked at $107K in Q3 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.